- Home
- ORIC vs ABL Comparison
ORIC vs ABL Comparison
Compare ORIC & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- ABL
- Stock Information
- Founded
- ORIC 2014
- ABL 2004
- Country
- ORIC United States
- ABL United States
- Employees
- ORIC N/A
- ABL N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- ABL Investment Managers
- Sector
- ORIC Health Care
- ABL Finance
- Exchange
- ORIC Nasdaq
- ABL Nasdaq
- Market Cap
- ORIC 750.6M
- ABL 757.0M
- IPO Year
- ORIC 2020
- ABL N/A
- Fundamental
- Price
- ORIC $8.50
- ABL $8.34
- Analyst Decision
- ORIC Strong Buy
- ABL Strong Buy
- Analyst Count
- ORIC 9
- ABL 4
- Target Price
- ORIC $18.75
- ABL $14.13
- AVG Volume (30 Days)
- ORIC 499.8K
- ABL 53.6K
- Earning Date
- ORIC 11-12-2024
- ABL 11-07-2024
- Dividend Yield
- ORIC N/A
- ABL N/A
- EPS Growth
- ORIC N/A
- ABL N/A
- EPS
- ORIC N/A
- ABL N/A
- Revenue
- ORIC N/A
- ABL $102,407,324.00
- Revenue This Year
- ORIC N/A
- ABL $67.69
- Revenue Next Year
- ORIC N/A
- ABL $61.70
- P/E Ratio
- ORIC N/A
- ABL N/A
- Revenue Growth
- ORIC N/A
- ABL 77.68
- 52 Week Low
- ORIC $6.33
- ABL $5.85
- 52 Week High
- ORIC $16.65
- ABL $13.25
- Technical
- Relative Strength Index (RSI)
- ORIC 37.50
- ABL 39.72
- Support Level
- ORIC $10.06
- ABL $8.17
- Resistance Level
- ORIC $11.11
- ABL $9.00
- Average True Range (ATR)
- ORIC 0.81
- ABL 0.44
- MACD
- ORIC -0.05
- ABL 0.00
- Stochastic Oscillator
- ORIC 13.00
- ABL 19.47
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About ABL Abacus Life Inc.
Abacus Life Inc is a vertically integrated alternative asset manager specializing in investing in life insurance products throughout the lifecycle of a life insurance policy.